These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4566004)

  • 1. Anti-thymocytic globulin in canine renal allotransplantation. II. Immunosuppressive and toxic effect with subsutaneous and intravenous administration.
    Collste LG
    Acta Chir Scand; 1972; 138(7):661-6. PubMed ID: 4566004
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-lymphocytic globulin in canine renal allotransplantation. I. Histologic and immunohistologic findings for two preparations given by subcutaneous and intravenous routes.
    Collste LG; Wasserman J; Bergstrand A; Groth CG
    Acta Chir Scand; 1972; 138(7):655-60. PubMed ID: 4566003
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical use of antilymphocyte globulin.
    Najarian JS; Simmons RL
    N Engl J Med; 1971 Jul; 285(3):158-66. PubMed ID: 4103453
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous antilymphocyte globulin in human cadaveric renal allotransplantation. Clinical and immunologic observations.
    Collste LG
    Acta Chir Scand; 1972; 138(8):765-74. PubMed ID: 4565721
    [No Abstract]   [Full Text] [Related]  

  • 5. Potency and maintenance in antilymphocyte globulin fractionation: contrasting tests of effectiveness in an animal model.
    Salerni B; Simmonian SJ; Kay RG; Latham WC; Brown KJ; Birtch AG; Busch GJ; Lukl P; Woods JE
    Surg Forum; 1970; 21():277-9. PubMed ID: 4936983
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of intravenous route for administration of antilymphocyte globulins in humans.
    Traeger J; Touraine JL; Fries D; Berthoux F
    Transplant Proc; 1971 Mar; 3(1):749-53. PubMed ID: 4937966
    [No Abstract]   [Full Text] [Related]  

  • 7. The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.
    James K; Pullar DM; Morton JB; Dalton RG; Nolan B; Woodruff MF
    Clin Exp Immunol; 1971 Apr; 8(4):529-42. PubMed ID: 4995934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of antilymphocyte globulin in kidney transplantation in the early postoperative period].
    Radzivil GG; Lobanova ED; L'vitsyna GM; Kutasova IV; Vasina TA
    Klin Med (Mosk); 1975 Mar; 53(3):26-33. PubMed ID: 1090779
    [No Abstract]   [Full Text] [Related]  

  • 9. Antilymphocyte serum and lymphatic system. I. The effect of regional administration on the survival of skin allografts.
    Málek P; Kolc J; Hasková V; Zástava V
    Transplantation; 1969 Oct; 8(4):333-7. PubMed ID: 4914422
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
    Cerilli GJ; Miller A; Hattan D
    Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjunct antilymphocyte globulin therapy in canine renal allograft recipients: importance of preoperative administration.
    Kelly GE; Drummond M; Sheil AG
    J Surg Res; 1974 Jun; 16(6):620-3. PubMed ID: 4599465
    [No Abstract]   [Full Text] [Related]  

  • 12. Antilymphoblast globulin for renal allograft prolongation.
    Simmons RL; Condie R; Najarian JS
    Transplant Proc; 1972 Dec; 4(4):487-90. PubMed ID: 4566792
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical use of antilymphocyte globulin (ALG) (author's transl)].
    Brendel W; Seifert J; Ring J
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1361-8. PubMed ID: 809676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal allograft in the dog. A new method for survival prolongation].
    Liégeois A; Caridis T; Barrett I; Monaco AP
    Nouv Presse Med; 1973 May; 2(20):1351-4. PubMed ID: 4577259
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of long term survival of renal allografts after treatment with antilymphocyte antibody.
    Guttmann RD; Lindquist RR; Ockner SA; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):463-6. PubMed ID: 4944260
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical use of antilymphocyte serum in organ and tissue allotransplantation (survey of the literature)].
    Korenevskaia VA; Shumakov VI
    Khirurgiia (Mosk); 1972 Feb; 49(2):127-31. PubMed ID: 4572233
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of antilymphocyte serum on renal allograft survival in dogs with special reference to the cytotoxic titer and immunosuppressive activity.
    Matsukura M; Sekiguchi M; Endo S; Kurosawa T; Koishi T
    Jpn J Exp Med; 1971 Aug; 41(4):369-73. PubMed ID: 4936584
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
    Shanfield I; Wolf JS; Wren SF; MacLean LD; Hume DM
    Transplant Proc; 1973 Mar; 5(1):533-4. PubMed ID: 4572113
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactivities to horse anti-lymphocyte globulin. I. Induction of immunologic tolerance in man.
    Gewurz H; Moberg A; Simmons R; Pollara B; Soll R; Najarian S
    Int Arch Allergy Appl Immunol; 1970; 39(2-3):113-20. PubMed ID: 4990554
    [No Abstract]   [Full Text] [Related]  

  • 20. Nursing review of the use and administration of antilymphocyte globulin in renal transplantation.
    Downs SA
    J Am Assoc Nephrol Nurses Tech; 1981 Feb; 8(1):49-51. PubMed ID: 7009705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.